Literature DB >> 25449855

Attention enhancing effects of methylphenidate are age-dependent.

Shevon E Bhattacharya1, Jed S Shumsky2, Barry D Waterhouse3.   

Abstract

The psychostimulant methylphenidate (MPH, Ritalin®) is used to treat a variety of cognitive disorders. MPH is also popular among healthy individuals, including the elderly, for its ability to focus attention and improve concentration, but these effects have not been shown to be comparable between aged and adult subjects. Thus, we tested whether MPH would improve performance in sustained attention in both adult and aged rats. In addition, we tested the impact of visual distraction on performance in this task and the ability of MPH to mitigate the effects of distraction. Adult (6-12 months) and aged (18-22 months) male Sprague-Dawley rats were given oral MPH, and their cognitive and motor abilities were tested. Results suggest that while MPH improves task performance in adults; there is no improvement in the aged animals. These outcomes suggest that the use of MPH for cognitive enhancement in elderly individuals may be ineffective.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Attention; Methylphenidate; Monoamine; Psychostimulant; Rat

Mesh:

Substances:

Year:  2014        PMID: 25449855      PMCID: PMC4289654          DOI: 10.1016/j.exger.2014.11.006

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  38 in total

1.  Decline in visual attention and spatial memory in aged rats.

Authors:  J L Muir; W Fischer; A Björklund
Journal:  Neurobiol Aging       Date:  1999 Nov-Dec       Impact factor: 4.673

2.  Changes in cortical noradrenergic axon terminals of locus coeruleus neurons in aged F344 rats.

Authors:  Y Ishida; T Shirokawa; Y Komatsu; K Isobe
Journal:  Neurosci Lett       Date:  2001-07-20       Impact factor: 3.046

Review 3.  Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder.

Authors:  Craig W Berridge; David M Devilbiss
Journal:  Biol Psychiatry       Date:  2010-09-26       Impact factor: 13.382

Review 4.  Methylphenidate treatment of negative symptoms in patients with dementia.

Authors:  I Galynker; C Ieronimo; C Miner; J Rosenblum; N Vilkas; R Rosenthal
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1997       Impact factor: 2.198

5.  Iron status and stores decline with age in Lewis rats.

Authors:  N Ahluwalia; M A Gordon; G Handte; M Mahlon; N Q Li; J L Beard; D Weinstock; A C Ross
Journal:  J Nutr       Date:  2000-09       Impact factor: 4.798

6.  Motor learning deficits in aged rats are correlated with loss of cerebellar noradrenergic function.

Authors:  P Bickford
Journal:  Brain Res       Date:  1993-08-20       Impact factor: 3.252

7.  Pharmacokinetics of methylphenidate in man, rat and monkey.

Authors:  W Wargin; K Patrick; C Kilts; C T Gualtieri; K Ellington; R A Mueller; G Kraemer; G R Breese
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

8.  BDNF is necessary for maintenance of noradrenergic innervations in the aged rat brain.

Authors:  Wataru Matsunaga; Tetsuya Shirokawa; Kenichi Isobe
Journal:  Neurobiol Aging       Date:  2004-03       Impact factor: 4.673

9.  Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands.

Authors:  J McGaughy; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

10.  Effects of iron supplementation on attention deficit hyperactivity disorder in children.

Authors:  Eric Konofal; Michel Lecendreux; Juliette Deron; Martine Marchand; Samuele Cortese; Mohammed Zaïm; Marie Christine Mouren; Isabelle Arnulf
Journal:  Pediatr Neurol       Date:  2008-01       Impact factor: 3.372

View more
  3 in total

1.  Atomoxetine improves memory and other components of executive function in young-adult rats and aged rhesus monkeys.

Authors:  Patrick M Callahan; Marc R Plagenhoef; David T Blake; Alvin V Terry
Journal:  Neuropharmacology       Date:  2019-05-18       Impact factor: 5.250

Review 2.  Psychostimulants As Cognitive Enhancers in Adolescents: More Risk than Reward?

Authors:  Kimberly R Urban; Wen-Jun Gao
Journal:  Front Public Health       Date:  2017-09-26

3.  Safety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans.

Authors:  Elizabeth B de Sousa Fernandes Perna; Eef L Theunissen; Patrick C Dolder; Natasha L Mason; Nadia R P W Hutten; Stefan W Toennes; Kim P C Kuypers; Johannes G Ramaekers
Journal:  Front Pharmacol       Date:  2018-07-06       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.